DNTOX
D├╝sseldorf
About DNTOX
We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, it is supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.5M
- Funding stage: Seed
- Last round: Seed (Jun 2023)
- Website: dntox.de
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/dntox-104389 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.